Seamless Therapeutics today announced the appointment of Alvin Shih, M.D., M.B.A., as an Independent Director to its Board. Dr. Shih is an experienced drug developer and physician with a track record of successfully building and guiding companies focused on multiple therapeutic areas, including rare diseases. Dr Shih’s appointment to their Board will further strengthen the company as it advances its unique pipeline of programmable recombinase products to the clinic.
